Discover Cancer research trials taking place in and around St. Louis.

Arch Oncology is advancing its unique cancer-killing antibody therapies in clinical trials.

BioGenerator Ventures portfolio has raised $2.2 billion in follow-on capital, with much of the success involving one company in 2021.

Immunophotonics announced it has raised $21.4 million dollars to advance clinical trials of its cancer treatment.

If Wugen is not working on its memory natural killer cell technology, it’s not top secret that Wugen has ‘007.’

Federal dollars from Cancer Moonshot is expected to help companies develop innovative cancer treatments and diagnostics in St. Louis.

Zika virus gives a powerful boost to immunotherapy, effectively destroying deadly brain cancer in lab mice.

The newly formed Brain Tumor Center is part of Siteman Cancer Center and the Washington University Medical Campus in St. Louis.

Geneoscopy wants to improve widespread colorectal cancer detection and prevention through participation with at-home collection kits.

World Trade Center St. Louis established a connection for an expansion of the Siteman Cancer Center to Shouzou, China.